Inactive Instrument

Ophthalix Inc Stock Other OTC

US6837362010

Biotechnology & Medical Research

Wize Pharma Inc, formerly Ophthalix, Inc., is a clinical-stage biopharmaceutical company. The Company is focused on the treatment of ophthalmic disorders, including dry eye syndrome (DES) and other inflammatory conditions. The Company markets, sells and distributes a formula known as LO2A, which protects ocular surface tissues. LO2A is a drug developed for the treatment of DES and other ophthalmological illnesses, including conjunctivochalasis (CCH) and sjogren's syndrome (sjogren's).

Employees

Sector

Biotechnology & Medical Research

More about the company

The best tools reserved for subscribers to boost the performance of your investments!

12/03/21	Insider Trends: Wize Pharma Insider 90-Day Buying Trend Added to with Purchase	MT
12/03/21	Insider Trends: Insider Purchase Adds to Wize Pharma Positive Trend	MT
12/03/21	Insider Trends: Insider Buying Continued with Purchase of Wize Pharma Stock	MT

26/03/21	Wize Pharma : to change name to Mawson Infrastructure Group Inc	AQ
24/03/21	MAWSON INFRASTRUCTURE GROUP INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	AQ
11/03/21	WIZE PHARMA, INC. : Completion of Acquisition or Disposition of Assets, Unregistered Sale of Equity Securities, Changes in Control or Registrant, Change in Directors or Principal Officers, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)	AQ
02/03/21	WIZE PHARMA : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-K)	AQ
22/02/21	Vertua Limited (NSX:VERA) Cosmos Investment Impact	AQ

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
OPHTHALIX INC	-9.09%	-9.09%	-	-	30.31M
LONZA GROUP AG	+1.46%	+5.87%	+5.75%	+33.71%	47.56B
IQVIA HOLDINGS INC.	+2.67%	+2.31%	+47.50%	+38.37%	44.09B
BEONE MEDICINES AG	-1.38%	+3.42%	+9.39%	+88.88%	41.5B
REVOLUTION MEDICINES, INC.	+4.78%	+2.01%	+352.12%	+566.20%	40.88B
CELLTRION, INC.	-0.62%	+0.11%	+1.12%	+46.02%	29.67B
MEDPACE HOLDINGS, INC.	+0.56%	+0.67%	+25.08%	+155.71%	17.23B
EUROFINS SCIENTIFIC SE	+2.05%	+4.04%	+24.47%	+41.67%	15.06B
ASCENDIS PHARMA A/S	+3.39%	-6.86%	-	-	14.65B
TEMPUS AI, INC.	+7.38%	+17.54%	-2.25%	-	13.82B
Average	+1.08%	+0.69%	+57.90%	+138.65%	29.39B
Weighted average by Cap.	+1.87%	+0.96%	+71.88%	+147.49%

Ophthalix Inc Stock Other OTC

Stocks

US6837362010

Biotechnology & Medical Research

Latest news: Ophthalix Inc

Press Releases: Ophthalix Inc

Quotes and Performance

Other Biotechnology & Medical Research

Company Profile